Transdermal (TTS) fentanyl in cancer pain management

[1]  M. Lema,et al.  Intravenous abuse of transdermal fentanyl therapy in a chronic pain patient. , 1993, Anesthesiology.

[2]  M. Boswell,et al.  Fentanyl transdermal system overdose secondary to cutaneous hyperthermia. , 1993, Anesthesia and analgesia.

[3]  S. Lustik,et al.  The use of transdermal fentanyl in a six-year-old patient with neuroblastoma and diffuse abdominal pain. , 1993, Journal of pain and symptom management.

[4]  M. Zenz,et al.  [Fentanyl-TTS for postoperative pain therapy. A new alternative?]. , 1993, Der Anaesthesist.

[5]  R. Portenoy,et al.  Transdermal Fentanyl for Cancer Pain Repeated Dose Pharmacokinetics , 1993, Anesthesiology.

[6]  S. Grond,et al.  Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients , 1992, PAIN.

[7]  R. Slover,et al.  Transdermal fentanyl: clinical trial at the University of Colorado Health Sciences Center. , 1992, Journal of pain and symptom management.

[8]  M. Levy,et al.  Transdermal fentanyl: seeding trial in patients with chronic cancer pain. , 1992, Journal of pain and symptom management.

[9]  L. Hogan,et al.  Transdermal fentanyl for chronic cancer pain: detailed case reports and the influence of confounding factors. , 1992, Journal of pain and symptom management.

[10]  K. Lehmann,et al.  Transdermal fentanyl: clinical pharmacology. , 1992, Journal of pain and symptom management.

[11]  L. Strause,et al.  Transdermal fentanyl use in hospice home-care patients with chronic cancer pain. , 1992, Journal of pain and symptom management.

[12]  Suneel K. Gupta,et al.  System functionality and physicochemical model of fentanyl transdermal system. , 1992, Journal of pain and symptom management.

[13]  S. Grond,et al.  Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. , 1991, Journal of pain and symptom management.

[14]  M. Marcus,et al.  An open label study of oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough cancer pain , 1991, Pain.

[15]  M. Southam,et al.  Transdermal Permeation: Physiological and Physicochemical Aspects , 1991 .

[16]  E. Freye.  Opioide in der Medizin , 1991 .

[17]  L. Mather,et al.  Pharmacokinetics and Pharmacodynamics , 1991 .

[18]  M. Southam,et al.  Transdermal Fentanyl: an Overview of Pharmacokinetics, Efficacy and Safety , 1991 .

[19]  R. Portenoy,et al.  Breakthrough pain: definition, prevalence and characteristics , 1990, Pain.

[20]  K. Foley,et al.  Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. , 1990, Journal of pain and symptom management.

[21]  H. Owen,et al.  The efficacy of transdermal fentanyl in the treatment of postoperative pain: a double-blind comparison of fentanyl and placebo systems , 1990, Pain.

[22]  D. Rowbotham,et al.  Transdermal fentanyl for the relief of pain after upper abdominal surgery. , 1989, British journal of anaesthesia.

[23]  D. Stanski,et al.  Absorption characteristics of transdermally administered fentanyl. , 1989, Anesthesiology.

[24]  J. Plummer,et al.  The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects , 1989, Pain.

[25]  J. Miser,et al.  Transdermal fentanyl for pain control in patients with cancer , 1989, Pain.

[26]  S. Hameroff,et al.  Transdermal Fentanyl: Pharmacokinetics and Preliminary Clinical Evaluation , 1989, Pharmacotherapy.

[27]  M. Goldberg,et al.  PHARMACOKINETICS OF FENTANYL FOLLOWING TRANSDERMAL APPLICATION , 1988 .

[28]  F. Holley,et al.  Postoperative analgesia with fentanyl: pharmacokinetics and pharmacodynamics of constant-rate i.v. and transdermal delivery. , 1988, British journal of anaesthesia.

[29]  D. Rowbotham,et al.  Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients. , 1988, British journal of anaesthesia.

[30]  Michael J. Cousins,et al.  Fentanyl Blood Concentration‐Analgesic Response Relationship in the Treatment of Postoperative Pain , 1988, Anesthesia and analgesia.

[31]  L. Mather.  Clinical Pharmacokinetics of Fentanyl and its Newer Derivatives , 1983, Clinical pharmacokinetics.

[32]  A. Michaels,et al.  Drug permeation through human skin: Theory and invitro experimental measurement , 1975 .

[33]  R. Scheuplein,et al.  Permeability of the skin. , 1971, Physiological reviews.